Results 11 to 20 of about 339,808 (204)

Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis

Scientific Reports, 2021
Risk factors associated with mortality in invasive pneumococcal disease remain unclear. The present work is a meta-analysis of studies that enrolled only patients with invasive pneumococcal disease and reported on mortality.
Hao Chen, Hiromi Matsumoto, Nobuyuki Horita, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko   +5 more
doaj   +2 more sources

Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain

Emerging Infectious Diseases, 2022
We analyzed the effect of COVID-19 on healthcare demand and invasive pneumococcal disease in children in Catalonia, Spain. Compared with 2018–2019, we noted large reductions in healthcare activities and incidence of invasive pneumococcal disease in 2020.
Pilar Ciruela, Núria Soldevila, Juan José García-Garcia, Sebastià González-Peris, Alvaro Díaz-Conradi, Alba Redin, Belén Viñado, Conchita Izquierdo, Carmen Muñoz-Almagro, Angela Domínguez   +9 more
doaj   +2 more sources

Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.

PLoS ONE, 2019
BackgroundDespite the widespread implementation of the pneumococcal conjugate vaccine, Streptococcus pneumoniae remains the leading cause of severe pneumonia associated with mortality among children less than 5 years of age worldwide, with the highest ...
James Samwel Ngocho, Best Magoma, Gaudencia Alois Olomi, Michael Johnson Mahande, Sia Emmanueli Msuya, Marien Isaäk de Jonge, Blandina Theophil Mmbaga   +6 more
doaj   +2 more sources

The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy

International Journal of Molecular Sciences, 2023
Despite innovative advances in anti-infective therapies and vaccine development technologies, community-acquired pneumonia (CAP) remains the most persistent cause of infection-related mortality globally.
R. Anderson, C. Feldman
semanticscholar   +1 more source

Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England

Emerging Infectious Diseases, 2022
During July–December 2021, after COVID-19 restrictions were removed in England, invasive pneumococcal disease incidence in children
M. Bertran, Z. Amin-Chowdhury, C. Sheppard, S. Eletu, D. Zamarreño, M. Ramsay, D. Litt, N. Fry, S. Ladhani   +8 more
semanticscholar   +1 more source

Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France

JAMA Network Open, 2022
Key Points Question Was the implementation of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic associated with changes in the incidence of invasive pneumococcal disease (IPD) and associated pneumococcal carriage and respiratory viral ...
A. Rybak, C. Levy, F. Angoulvant, A. Auvrignon, P. Gembara, K. Danis, S. Vaux, D. Lévy-Bruhl, S. van der Werf, S. Béchet, S. Bonacorsi, Zein Assad, A. Lazzati, M. Michel, F. Kaguelidou, A. Faye, R. Cohen, E. Varon, N. Ouldali   +18 more
semanticscholar   +1 more source

Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination

Clinical Infectious Diseases, 2022
Background The introduction and adoption of pneumococcal conjugate vaccines (PCVs) into pediatric national immunization programs (NIPs) has led to large decreases in invasive pneumococcal disease (IPD) incidence caused by vaccine serotypes. Despite these
L. Grant, M. Slack, C. Theilacker, J. Vojičić, Stephane B Dion, R. Reinert, L. Jodar, B. Gessner   +7 more
semanticscholar   +1 more source

Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales

EClinicalMedicine, 2018
Abdelmajid Djennad, Mary Ramsay, Richard Pebody, Norman K. Fry, Carmen Sheppard, Shamez Ladhani, Nick Andrews   +6 more
openalex   +2 more sources

Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021

medRxiv, 2021
Background: The incidence of invasive pneumococcal disease (IPD) decreased worldwide in 2020 and the first quarter of 2021, concurrent with non-pharmaceutical interventions (NPIs) intended to stymie transmission of SARS-CoV-2.
S. Perniciaro, M. P. van der Linden, D. Weinberger   +2 more
semanticscholar   +1 more source

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project

Microorganisms, 2021
Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13).
M. Deloria Knoll, Julia C. Bennett, Maria Garcia Quesada, E. Kagucia, Meagan E. Peterson, D. Feikin, A. Cohen, M. Hetrich, Yangyupei Yang, Jenna N. Sinkevitch, K. Ampofo, Laurie Aukes, S. Bacci, G. Bigogo, M. Brandileone, M. Bruce, R. Camilli, J. Castilla, Guanhao Chan, Grettel Chanto Chacón, P. Ciruela, H. Cook, M. Corcoran, R. Dagan, K. Danis, S. de Miguel, P. De Wals, S. Desmet, Y. Galloway, T. Georgakopoulou, L. Hammitt, M. Hilty, P. Ho, S. Jayasinghe, J. Kellner, J. Kleynhans, M. Knol, J. Kozáková, K. Kristinsson, S. Ladhani, C. Lara, M. E. León, T. Lepp, G. Mackenzie, L. Mad'arová, A. McGeer, Tuya Mungun, J. Mwenda, J. P. Nuorti, Néhémie Nzoyikorera, K. Oishi, L. D. de Oliveira, M. Paragi, T. Pilishvili, R. Puentes, E. Rafai, S. Saha, L. Savrasova, C. Savulescu, J. Scott, K. Scott, F. Serhan, L. Setchanova, Nadja Sinkovec Zorko, A. Skoczyńska, T. Swarthout, P. Valentiner-Branth, M. P. van der Linden, D. Vestrheim, A. von Gottberg, I. Yildirim, K. Hayford, The Pserenade Team   +72 more
semanticscholar   +1 more source